Title : Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.

Pub. Date : 2022 Feb 27

PMID : 35278900






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-kappaB-mediated signaling pathway. tubeimoside I nuclear factor kappa B subunit 1 Homo sapiens